Prosecution Insights
Last updated: November 04, 2026
Application No. 18/740,720

PROCESSES FOR FIXATION OF CARBON DIOXIDE

Non-Final OA §102§103
Filed
Jun 12, 2024
Priority
Jun 15, 2023 — provisional 63/521,323
Examiner
KANE, TREVOR LOGAN
Art Unit
1657
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Jupeng Bio (Hk) Limited
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
78 granted / 113 resolved
+9.0% vs TC avg
Strong +53% interview lift
Without
With
+53.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
26 currently pending
Career history
150
Total Applications
across all art units

Statute-Specific Performance

§101
5.7%
-34.3% vs TC avg
§103
43.0%
+3.0% vs TC avg
§102
15.4%
-24.6% vs TC avg
§112
29.4%
-10.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 113 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election of claims 1-42 in the reply filed on 8/14/26 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Claims 43-90 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 8/14/26. Applicant’s election of the species of Methanothermobacter thermautotrophicus, microfluidics device, subtilases, and centrifugation in the reply filed on 8/14/26 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Claims 5 and 12 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 8/14/26. Priority Application claims priority to 63/521, 323 provisional application with an effective filing date of 6/15/23. Claims of the instant application are supported by the provisional application and thus have a priority date of 6/15/23. Information Disclosure Statement The IDS has been considered except where references have been lined through. Drawings The drawings are objected to because the figures are not properly labeled. 37 CFR 1.84 (u)(1) states “The different views must be numbered in consecutive Arabic numerals, starting with 1, independent of the numbering of the sheets and, if possible, in the order in which they appear on the drawing sheet(s). Partial views intended to form one complete view, on one or several sheets, must be identified by the same number followed by a capital letter. View numbers must be preceded by the abbreviation "FIG." Where only a single view is used in an application to illustrate the claimed invention, it must not be numbered and the abbreviation "FIG." must not appear.” In the instant case, the view numbers for Figures are preceded by the word "Figure" instead of the abbreviation "FIG.". Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-3 and 6 are rejected under 35 U.S.C. 102((a)(2) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Shaw (US20230340401A1) While Shaw was published after the effective filing date of instant application, Shaw claims priority to 12/6/21 and therefore is valid prior art under 102(a)(2). Regarding claims 1, 6 Shaw teaches methods of combining methanotrophic bacterial biomass production with a methanation process (claim 1). Shaw teaches that the method comprises generating methane via a methanogenic biomethanation (fig 1 and [0003]). Shaw teaches the methane is produced using CO2 and H2 (fig 1). Shaw teaches the production of methane can be accomplished via Methanothermobacter thermautotrophicus (methanogenic archaea (claim 11). Shaw teaches that exemplary methanogenic species used can be Methanobacterium alcaliphilum ([0078]). Methanobacterium alcaliphilum is a methylotrophic bacteria as evidenced by instant claim 12. Shaw teaches that methane can be fermented in a single cell protein production bioreactor to produce a biomass and a CO2 gas (fig 1). Shaw teaches that liquid bioreactors are well known in the arts ([0101]). It would be obvious to one of ordinary skill in the arts to use the two claimed species as Shaw teaches both can be used in their invention. Regarding claim 2, Shaw teaches that the CO2 from the single cell protein production bioreactor can be routed to the biomethanation bioreactor (fig 1). Regarding claim 3, Shaw teaches that oxygen can be scrubbed (removed) to promote high levels of methane production ([0113]). Claims 4, 7-11, 13-14, and 16-22 are rejected under 35 U.S.C. 103 as being unpatentable over Shaw (US20230340401A1), as applied to claims 1-3 and 6 above, and further in view of Dyson (WO2018144965A1). Regarding claim 4, Shaw does not explicitly teach the ratio of CO2 to H2. Dyson teaches microorganisms and bioprocesses are provided that convert gaseous substrates, such as renewable H2 and waste CO2 producer gas, or syngas into high-protein biomass that may be used directly for human nutrition, or as a nutrient for plants, fungi, or other microorganisms, or as a source of soil carbon, nitrogen, and other mineral nutrients (abstract). Dyson teaches the lysate can be further separated into a faction containing protein which can be used as a nutritional supplement ([377-378]). Dyson teaches the H2 can be 71% and the CO2 9% ([464]). Dyson further teaches the ratio of the gases can be adjusted before being delivered to the microorganisms ([70]). Therefore, this ratio is a result effective variable and one of ordinary skill in the arts would be motivated to experiment with this ratio. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the gas ratios of Dyson in the invention of Shaw One of ordinary skill in the art would be motivated to do so because these gas ratios have been successfully used to culture microorganisms, and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination yielded nothing more than predictable results to one of ordinary skill in the art. There would be a reasonable expectation of success as both Shaw and Dyson are in the same field of endeavor of culturing microorganisms. Regarding claims 7 and 8, Dyson teaches that the amount of H2 consumed alters the biomass (fig 4). As discussed above, the ratio of CO2 to H2 was a result effective variable, so to is the amount of CO2 or H2 consumed, so one of ordinary skill in the arts would be motivated to experiment with these variables. Regarding claim 9, Dyson teaches that the cells can grow from 9-30 hours before collection (example 2). Regarding claim 10 While Shaw and Dyson does not measure methane production, the cited combination teaches essentially the same fermentation using the same microorganisms as in the claimed method and it would have been obvious to use routine experimentation to discover the optimal/workable range of methane productivity (see MPEP 2144.05). Regarding claim 11, Dyson teaches less than 10% of the input carbon is lost as CO2 (>90% conversion rate) ([423]). Regarding claim 13, Shaw teaches the biomass can be separated via centrifugation to a liquid and a cell precipitate (cell free permeate and cell containing suspension) ([0044]). Shaw teaches the cell precipitate can be further processed including lysis (rupturing cell membrane) ([0045]). Shaw does not explicitly teach fractionating the first homogenate. Dyson teaches microorganisms and bioprocesses are provided that convert gaseous substrates, such as renewable H2 and waste CO2 producer gas, or syngas into high-protein biomass that may be used directly for human nutrition, or as a nutrient for plants, fungi, or other microorganisms, or as a source of soil carbon, nitrogen, and other mineral nutrients (abstract). Dyson teaches the lysate can be further separated into a faction containing protein which can be used as a nutritional supplement ([377-378]). Regarding claim 14, Dyson teaches the cells can be grown to 38 g dry mass/L ([449]). This falls within the claimed range and therefore the claimed range is obvious. Regarding claim 16, Shaw teaches the cultures are maintained at a pH of 6-8 ([0027]) This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 17-19, Dyson teaches subtilsin (subtilase) can be added at 55 oC for 24 hours ([561]). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 20, Dyson teaches cellular fractions can be separated via centrifugation ([377]). Regarding claim 21, Dyson teaches the nucleic acid concentration can be 0.5% -9% ([396]). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 22, Dyson teaches the concentrate protein can be dryed to 55% or higher (412). Dyson teaches the protein can be concentrated to 90% or more (413). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Claim 15 is rejected under 35 U.S.C. 103 as being unpatentable over Shaw and Dyson as applied to claims 1-4, 7-11, 13-14, and 16-22 above, and further in view of Lu, Haiwei, et al. "Rapid additive-free bacteria lysis using traveling surface acoustic waves in microfluidic channels." Lab on a Chip 19.24 (2019): 4064-4070. Regarding claim 15, Shaw teaches a wide range of possible methods for cell lysis ([0046]), but Shaw and Dyson do not explicitly teach microfluidics for cell lysis. Lu teaches microfluidics for cell lysis (title). Lu teaches the method is rapid and applicable to all bacterial types (abstract). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to replace the lysis methods of Shaw and Dyson with the microfluidics of Lu. One of ordinary skill in the art would be motivated to do so because these microfluidics have been successfully used to lyse cells, and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination yielded nothing more than predictable results to one of ordinary skill in the art. Further, Lu teaches the method is rapid and effective against all bacterial types. There would be a reasonable expectation of success as Shaw, Dyson, and Lu are in the same field of endeavor of cell lysis. Claims 23-42 are rejected under 35 U.S.C. 103 as being unpatentable over Dyson and Shaw and Lu, as applied to claims 1-4, 7-11 and 13-22 above, and further in view of Nandy (US20250066830A1.) while Nandy was published after the effective filing date of instant application it claims priority to 1/7/22 and therefore is valid prior art under 35 USC 102(a)(2). Regarding claim 23, Shaw teaches the biomass can be separated via centrifugation to a liquid and a cell precipitate (cell free permeate and cell containing suspension) ([0044]). Shaw teaches the cell precipitate can be further processed including lysis (rupturing cell membrane) ([0045]). Shaw does not explicitly teach fractionating the first homogenate or explicitly teach the processing of the methanogenic archae. Dyson teaches microorganisms and bioprocesses are provided that convert gaseous substrates, such as renewable H2 and waste CO2 producer gas, or syngas into high-protein biomass that may be used directly for human nutrition, or as a nutrient for plants, fungi, or other microorganisms, or as a source of soil carbon, nitrogen, and other mineral nutrients (abstract). Dyson teaches the lysate can be further separated into a faction containing protein which can be used as a nutritional supplement ([377-378]). Dyson and Shaw does not explicitly teach the processing of the methanogenic archaea. Nandy teaches methods of producing single cell protein from gas and carbon (abstract). Nandy teaches that the biomass can be collected from methanogenic microorganisms (claim 24). Nandy teaches their method meets the need for increased protein demand ([0005-0007]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to process the methanogenic archaea of Dyson and Shaw as taught by Nandy. One of ordinary skill in the art would be motivated to do so because Nandy teaches this meets the need of increased protein demand. Further, One of ordinary skill in the art would be motivated to do so because these processing steps have been successfully used to generate protein, and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination yielded nothing more than predictable results to one of ordinary skill in the art. There would be a reasonable expectation of success as Dyson, Shaw and Nandy are in the same field of endeavor of protein production from microorganisms. Regarding claim 24, Dyson teaches the cells can be grown to 38 g dry mass/L ([449]). This falls within the claimed range and therefore the claimed range is obvious. Regarding claim 25, Shaw teaches a wide range of possible methods for cell lysis ([0046]), but Shaw and Dyson do not explicitly teach microfluidics for cell lysis. Lu teaches microfluidics for cell lysis (title). Lu teaches the method is rapid and applicable to all bacterial types (abstract). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to replace the lysis methods of Shaw and Dyson with the microfluidics of Lu. One of ordinary skill in the art would be motivated to do so because these microfluidics have been successfully used to lyse cells, and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination yielded nothing more than predictable results to one of ordinary skill in the art. Further, Lu teaches the method is rapid and effective against all bacterial types. There would be a reasonable expectation of success as Shaw, Dyson, and Lu are in the same field of endeavor of cell lysis. Regarding claim 26, Shaw teaches the cultures are maintained at a pH of 6-8 ([0027]) This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 27-29, Dyson teaches subtilsin (subtilase) can be added at 55 oC for 24 hours ([561]). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 30, Dyson teaches cellular fractions can be separated via centrifugation ([377]). Regarding claim 31, Dyson teaches the nucleic acid concentration can be 0.5% -9% ([396]). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 32, Dyson teaches the concentrate protein can be dried to 55% or higher (412). Dyson teaches the protein can be concentrated to 90% or more (413). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 33, Shaw teaches the biomass can be separated via centrifugation to a liquid and a cell precipitate (cell free permeate and cell containing suspension) ([0044]). Shaw teaches the cell precipitate can be further processed including lysis (rupturing cell membrane) ([0045]). Shaw does not explicitly teach fractionating the first homogenate or explicitly teach the processing combination of the methanogenic and methanotrophic microorganism. Dyson teaches microorganisms and bioprocesses are provided that convert gaseous substrates, such as renewable H2 and waste CO2 producer gas, or syngas into high-protein biomass that may be used directly for human nutrition, or as a nutrient for plants, fungi, or other microorganisms, or as a source of soil carbon, nitrogen, and other mineral nutrients (abstract). Dyson teaches the lysate can be further separated into a faction containing protein which can be used as a nutritional supplement ([377-378]). Dyson and Shaw does not explicitly teach the processing of the combination of the methanogenic and methanotrophic microorganism. Nandy teaches methods of producing single cell protein from gas and carbon (abstract). Nandy teaches that the biomass can be collected from methanogenic microorganisms (claim 24). Nandy teaches their method meets the need for increased protein demand ([0005-0007]). Nandy teaches the protein can be a combination of the methanogenic and methanotrophic microorganism ([0171]). Regarding claim 34, Dyson teaches the cells can be grown to 38 g dry mass/L ([449]). This falls within the claimed range and therefore the claimed range is obvious. Regarding claim 35, Shaw teaches a wide range of possible methods for cell lysis ([0046]), but Shaw and Dyson do not explicitly teach microfluidics for cell lysis. Lu teaches microfluidics for cell lysis (title). Lu teaches the method is rapid and applicable to all bacterial types (abstract). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to replace the lysis methods of Shaw and Dyson with the microfluidics of Lu. One of ordinary skill in the art would be motivated to do so because these microfluidics have been successfully used to lyse cells, and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination yielded nothing more than predictable results to one of ordinary skill in the art. Further, Lu teaches the method is rapid and effective against all bacterial types. There would be a reasonable expectation of success as Shaw, Dyson, and Lu are in the same field of endeavor of cell lysis. Regarding claim 36, Shaw teaches the cultures are maintained at a pH of 6-8 ([0027]) This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 37-39, Dyson teaches subtilsin (subtilase) can be added at 55 oC for 24 hours ([561]). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 40, Dyson teaches cellular fractions can be separated via centrifugation ([377]). Regarding claim 41, Dyson teaches the nucleic acid concentration can be 0.5% -9% ([396]). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Regarding claim 42, Dyson teaches the concentrate protein can be dryed to 55% or higher (412). Dyson teaches the protein can be concentrated to 90% or more (413). This overlaps the claimed range and therefore the claimed range is prima facia obvious. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to TREVOR L KANE whose telephone number is (571)272-0265. The examiner can normally be reached M-F 7:00 am-4:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Louise Humphrey can be reached at 571-272-5543. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TREVOR KANE/Examiner, Art Unit 1657 /ROBERT J YAMASAKI/Primary Examiner, Art Unit 1657
Read full office action

Prosecution Timeline

Jun 12, 2024
Application Filed
Oct 20, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12782358
REAGENT FOR MEASURING B-GLUCAN, METHOD FOR PRODUCING SAME AND USE THEREOF
2y 9m to grant Granted Nov 03, 2026
Patent 12767938
POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYN-DROMES
4y 1m to grant Granted Oct 20, 2026
Patent 12758592
MAGNETIC BACTERIA, NON-THERAPEUTIC AND THERAPEUTIC USES THEREOF
4y 8m to grant Granted Oct 13, 2026
Patent 12735732
Method for preparing ultra-low molecular weight Dendrobium oligosaccharides by enzymatic hydrolysis and its application
1y 11m to grant Granted Sep 15, 2026
Patent 12721349
METHOD FOR PROMOTING BACTERIAL CELL WALL DEGRADATION
4y 11m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
99%
With Interview (+53.4%)
3y 4m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 113 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month